Latest: FDA Approves New Biosimilar for Oncology Treatment

Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML

19 August, 2025

0 Mins

Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease progression.

Tags:

Author

American Journal Managed Care

Vormatrigine Reduces Seizures in Phase 2 RADIANT Study, Postpartum Depression in MS Women, Ianalumab Produces Significant Phase 3 Data in Sjögren’s disease

Diagnostic Imaging's Weekly Scan: August 10 — August 16

📢

300x250 Banner

Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML

Tags:

American Journal Managed Care

Vormatrigine Reduces Seizures in Phase 2 RADIANT Study, Postpartum Depression in MS Women, Ianalumab Produces Significant Phase 3 Data in Sjögren’s disease

Diagnostic Imaging's Weekly Scan: August 10 — August 16

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition